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Copyright © 2011 JCBN 2011 This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unre- stricted use, distribution, and reproduction in any medium, pro- vided the original work is properly cited. Gallic acid is widely distributed in plants, fruits and foods with a
range of biological activities. In the present study the possible
mechanisms of gallic acid anticancer properties were explored in
A549, a human lung adenocarcinoma cell line. Our study shows
that it inhibited the A549 cell growth and decreased cell viability
monitored at 24 h. It also inhibited cell proliferation in dose  and
time dependent manner as measured by 3 [4,5 methylthiazol 2 yl] 
2,5 diphenyl tetrazolium bromide assay at 24 and 48 h. Morpho 
logical examination of the cells after gallic acid treatment showed
the typical feature of cell death such as cell shrinkage and round 
ing up of the cells. Clonogenic assay indicated that gallic acid
treatments inhibited the colony formation. DNA fragmentation
assay indicated the disappearance of the genomic DNA in dose 
dependent manner. To find out possible mechanisms, mito 
chondrial potential and intracellular reactive oxygen species were
measured. It was observed that gallic acid treatment decreased
mitochondrial membrane potential and increased intracellular
reactive oxygen species. Further caspases activity was measured
and it was found that gallic acid activated the caspase 3 but not
caspase 8 indicating the involvement of intrinsic pathway of cell
apoptosis.
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Introduction Worldwide, lung cancer is the most common cancer in terms
of both occurrence and mortality, with the highest rates in
Europe and North America. Despite rapid advances in diagnostic
and operative techniques, lung cancer remains one of the most
difficult human malignancies to treat. The American Cancer
Society estimates that 214,440 persons in the United States
developed lung cancer in 2009, with 159,390 deaths. Lung cancer-
dependent deaths constituted 30% (men) and 26% (women) of the
estimated total cancer-related deaths in 2009. Data indicate that
while the overall incidence of lung cancer is declining, it continues
to rise in women.(1) The relative 5-year survival ratio of the
patients that had lung or bronchus cancer from 1995 to 2001 was
still quite low (15%) and was not improved very much compared
to the 1970’s (12%). From the 1950s, the incidence of lung
adenocarcinoma started to rise relative to other types of lung
cancers.(2)
Recently, multiple new chemotherapeutic agents have been
developed and some are in clinical trials.(3,4) Although some of
them have produced promising results, their therapeutic spectrum
is narrow along with toxicity. This toxicity problem at therapeutic
concentration induced scientists to search for anticancer com-
pounds derived from natural sources such as phytochemicals.
Keeping this in mind, the aim of the present paper is to explore the
anticancer property of gallic acid (GA; 3,4 5-triphydroxyl-benzoic
acid), a natural phytochemical, on A549 human lung cancer cell
lines.
GA, a polyhydroxylphenolic compound, is widely distributed
in various plants, fruits and foods.(5) As far as the toxicity is
concerned it has an LD50 dose of 5 g/kg body weight in rats.(6)
GA has various biological activities such as anti-bacterial, anti-
melanogenic, anti-viral and anti-inflammatory(7–9) besides anti-
cancer activity in various cancer cells.(10–14)
Materials and Methods
Cell Cultures. A549, human lung adenocarcinoma cell line
was maintained in DMEM (Dulbecco’s modified Eagle’s medium)
(Himedia, Mumbai, India) supplemented with 10% fetal bovine
serum (FBS), 100 units/ml penicillin and 100 µg/ml streptomycin
(Himedia, Mumbai, India). The cells were incubated in 5% CO2
humidified at 37°C for growth.
Evaluation of cell proliferation by MTT assay. The num-
ber of viable A549 cells after GA treatment was evaluated by
the MTT (3-[4,5-methylthiazol-2-yl]-2,5-diphenyl-tetrazolium
bromide) assay. In brief, A549 cells (1 × 104 cells/well) were
seeded in a 96-well plate and kept overnight for attachment. The
next day the medium was replaced with fresh medium with
various concentrations of GA (100–400 µM) and cells were
allowed to grow for 24 and 48 h. Four hours before completion of
incubation, 10 µl of MTT (10 mg/ml) was added in each well.
After completing the incubation, 100 µl of solubilization buffer
(10% SDS with 0.01 N HCl) was added to each well and incubated
overnight at room temperature. Color developed after the reaction
was measured at 550 nm using Bio-Tek microplate reader.
Evaluation of A549 cell count and viability by trypan
blue dye. In brief, 5 × 105 A549 cells were seeded in each well
of 6-well plate and kept overnight for attachment. Next day old
medium was replaced with fresh medium containing 0, 100 and
200 µM of GA and incubated for 24 h. Following incubation, the
supernatant pool was collected and adherent cells were trypsinized
and collected. Cell viability was performed by the dye exclusion
test with 0.5% trypan blue using a hemocytometer.
Clonogenic assay. In brief, 5 × 105 cells were seeded per
well in a 6-well plate and allowed to attach overnight. The next
day medium was replaced with fresh medium containing different
concentration (50, 100, 200 µM) of GA and incubated for 2 h.
Following incubation, cells were harvested by trypsinisation and
counted. For clonogenic assay 250 A549 cells in 4 ml medium
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were seeded in 6-well plate and were incubated at 37°C for 12
days without any disturbances. Following incubation, the medium
was removed and colonies were fixed and stained with 0.5%
methylene blue (dissolved in 50% ethanol). Colony counting was
performed with cellAnalyst software (AssaySoft, Inc., CA). The
experiment was carried out twice in triplicates.
DNA Fragmentation analysis. In brief, 7.5 × 105 cells per
well of 6-well plate were seeded and kept overnight for attach-
ment. Next day old medium was replaced with medium containing
0, 100, 200 and 400 µM GA and incubated for 24 h. Following
incubation, cells were collected and washed with 1 × PBS
(phosphate buffered saline), resuspended in 100 µl lysis buffer and
incubated for 1 h at 50°C. 10 µl of RNase (10 mg/ml) was added
to the lysate and further incubated for 1 h at 50°C. The DNA
samples were electrophoresed in a 1.8% agarose gel in TBE (Tris-
borate-EDTA) buffer (pH 8.0). The DNA bands were visualized
using a gel-doc system. The profile of the DNA band was analyzed
using Scion Image analysis software.
Detection of intracellular ROS levels. The intracellular
ROS (Reactive oxygen species) generation in A549 cells was
investigated using the 2',7'-dichlorofluorescein-diacetate (DCFH-
DA) dye. For measuring the intracellular ROS in individual
cells 5 × 105 cells were seeded on cover-slip in 6-well plate and
incubated overnight for attachment. Next day old medium was
replaced with fresh medium containing 0, 100 and 200 µM GA
and left for 2 h at 37°C. At the end of incubation cover-slip was
removed from the culture plate and stained with 40 µM DCFH-
DA for 30 min. Excess of the dye was removed by washing with
1 × PBS. Cover-slip was mounted on glass slide and images of
the cells were captured using 40× objectives under fluorescence
microscope.
For measuring total ROS level in the cells, 5 × 105 cells were
seeded in a 6-well plate and allowed to attach overnight. The next
day, medium was replaced by fresh medium containing 0, 100 and
200 µM of GA and allowed to incubate for 1 and 2 h. Following
incubations, the cells were harvested by trypsinization and washed
with PBS and resuspended in PBS containing 10 µM DCFH-DA.
Equal number of cells in 100 µl of DCFH-DA containing PBS
were distributed in each well of 96-well fluorimetry plate and
incubated at 37°C for 45 min. The plate was read using an excita-
tion of 485 nm and emission at 520 nm and graph was plotted
denoting the change in ROS level.
Assessment of MMP. For assessing the mitochondrial
membrane potential, A549 cells (5 × 105/well) were seeded in 6-
well plates and incubated overnight for attachment. Next day old
medium was replaced with fresh medium containing 200 µM
GA and incubated for 1 h. Cells were collected by trypsinization
and resuspended in 1 ml of DiO6 (3,3'-dihexyloxacarboxyanine
iodide) solution (40 nM DiO6 in 1 × PBS) and incubated for
30 min at room temperature. Fluorescence intensity (Ex/Em:
488/525) was measured using microtiter plate reader.
Detection of caspase 3 levels. In brief, 1 × 106 A549 cells
Fig. 1. Inhibition of A549 cell proliferation by gallic acid. In brief 1 × 104 cells were treated with 0, 100, 200 and 400 µM of gallic acid. A: 24 h MTT
assay, B: 48 h MTT assay. C: Morphology of A549 cells treated with different concentrations of gallic acid. ***: p<0.001. J. Clin. Biochem. Nutr. | January 2011 | vol. 48 | no. 1 | 87
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were seeded in a 6-well plate and allowed to attach overnight. The
next day medium was replaced by fresh medium containing 0, 100
and 200 µM of GA and incubated for 1, 3 and 6 h. At the end of
incubations, cells were collected by trypsinization and washed
twice in PBS. Cell pellet was resuspended in 75 µl of 1 × lysis
buffer and incubated on ice for 15–20 min. Cell lysate were
centrifuged at 20,000 rpm for 15 min at 4°C. Pellet was discarded
and supernatant was transferred to new tubes and stored at −80°C
till analysis. The supernatants were used for estimation of caspase-
3 as instructed by the manufacturer in 96-well microtiter plate.
Statistical analysis. All values are expressed as means ± SE.
Statistical significance was set at *p<0.05; **p<0.05; ***p<0.001.
Results
GA inhibits A549 cells growth and proliferation. As
shown in Fig. 1 GA inhibited A549 cell proliferation in dose-
and time-dependent manner. From Fig. 1 it is also clear that this
cell growth inhibition was limited to 200 µM. After 200 µM there
was not much cell growth inhibition. From examination of A549
cells morphology at 24 h after 100, 200 and 400 µM GA treatment
it was observed that cells started shrinking showing the symptoms
of the cell death. Further, total cell count and the cell viability were
measured after treating cells with GA for 24 h. From Fig. 2A, it
was clear that the total cell count started decreasing in the GA
treated group and this effect was observed in a concentration-
dependent manner. As shown in Fig. 2B, the percent viability of
cells decreased with GA treatment but not in a concentration-
dependent manner.
GA inhibited A549 colony growth. The anticancer property
of GA was also examined by clonogenic assay. The colony is
defined to consist of at least 50 cells. As shown in Fig. 3, GA
significantly decreased A549 colony growth in a concentration-
dependent manner.
GA induces cellular DNA fragmentation. From Fig. 4, it
is clear that GA leads to a concentration dependent decrease in the
total genomic DNA. However, no clear DNA ladder pattern was
observed in this cell line.
GA induced intracellular ROS in A549 cells. As shown in
Fig. 5A–C, GA treatment induced the ROS level in cell as mea-
sured by fluorescence microscopy study at individual cell level.
From these cell images it is clear that the fluorescence intensity
of individual cells increased in a concentration-dependent manner
indicating ROS generation by GA. Further, total cellular ROS was
measured fluorimetrically at 1 and 2 h post treatment with GA and
this observation collaborated well with fluorescence microscopy
results (Fig. 5D).
GA disrupts mitochondrial membrane potential in
A549 cells. Since it is known that increase in ROS level disrupt
the MMP to execute the apoptosis, the third experiment was
carried out to find out the possible mechanisms was the measure-
ment of MMP. As shown in Fig. 6, 1 h incubation of cells with GA
marginally disrupted the MMP.
GA induces caspase 3 in A549 cells. Since disruption of
MMP leads to induction of apoptosis by intrinsic pathway via
caspase-3 induction, in the next experiment the level of caspase-3
was measured and it was found that treatment of A549 cells with
GA induced the caspase-3 (Fig. 7) but not caspase-8 (data not
shown) to execute the process of apoptosis.
Discussion
The relationship between diet and cancers has been implicated
in several epidemiological studies. The cancer incidence is
significantly lower in people whose diet consists largely of fruits
and vegetables than people whose diet consists of mainly animal
products.(15) The present paper focused on evaluating the effects
of GA, a dietary phytochemical on A549, human lung adeno-
carcinoma cell line in relation to cell growth inhibition, apoptosis
and their underlying mechanisms.
To determine the inhibitory concentration of GA on A549
cells, cell proliferation and cell viability was determined. It was
observed that exposure to GA for 24 h, A549 cell growth was
inhibited as it is clear from MTT assay and direct cell count
(Figs. 1 and 2). The morphological changes in cells clearly
indicate that cells undergo apoptosis at 24 h after incubation
with the concentration of GA chosen based on the MTT assays
(Fig. 1C). To study reproductive cell death further clonogenic
assay was carried out. Our finding shows that GA dose depend-
ently inhibited the A549 colony formation as compared to the
Fig. 2. Effect of gallic acid on A549 cell count and viability. A: Graph showing cell counting result and, B: Graph showing % cell viability. *: p<0.05;
**: p<0.05; ***: p<0.001.
Fig. 3. Effect of gallic acid on A549 cells in clonogenic assay. The
graph shows the number of colonies formed on the culture plate 12
days after treatment. *: p<0.05; ***: p<0.001.doi: 10.3164/jcbn.11 004FR
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control cells (Fig. 3). This indicates that GA decreases the poten-
tial of individual cells to form a colony and thereby acts as an
anti-cancer drug. This finding well corroborated with our cell
proliferation and cell count studies. Further DNA fragmentation
assay was performed for study of the apoptosis induction by GA.
Here we did not find clear DNA ladder pattern in A549 cells but
the concentration dependent degradation of genomic DNA was
observed in cells treated with GA (Fig. 4).
To gain insight into the molecular mechanism involved in GA
induced apoptosis, the level of ROS, change in MMP and the
activation of caspase-3 were assessed in A549 cells. GA has been
reported to have both pro-oxidant and antioxidant properties.(16,17)
Accumulation of ROS coupled with an increase in oxidative
stress has been implicated in the pathogenesis of several disease
including cancers. Increasing evidence suggests that apoptosis
induced by GA is associated with oxidative stress derived from
ROS and mitochondrial dysfunction.(11,18) Our result indicates that
the intracellular ROS levels were significantly increased in A549
cells treated with GA for 1 and 2 h (Fig. 5). Although cancer cells
have an increased ROS as compared to healthy cells, the increased
ROS is believed to be responsible for many novel cancer cell
properties including loss of cell senescence. However, an increase
of ROS beyond threshold would result in irreversible DNA
damage that would translate in the activation of apoptosis
pathway. GA has shown a 2 fold increase in ROS as compared to
the control cells. This is in correlation with other reports that
provide substantial evidence that apoptotic cells generally exhibit
an increase in ROS levels. Loss in membrane potential is another
major biochemical change in cells undergoing apoptosis. Our
study showed that there is a 31% decrease in the MMP in control
cells compared to 200 µM GA treated cells after 1 h of incubation
(Fig. 6). Caspases activity was quantified by colorimetric assay.
Although we estimated both caspase-3 and -8, our studies have
shown a clear increase in the caspase-3 activity (Fig. 7) but not the
caspase-8 (data not shown), indicating that GA induced apoptosis
in A549 cells is by the activation of caspase-3 pathway (intrinsic
pathway). The maximum activation of caspase-3 was seen at 1 and
3 h and showed a slight decrease compared to earlier values at 6 h.
Fig. 4. DNA fragmentation assay. Lane 1: control cells, Lane 2, Lane 3, Lane 4 are 100, 200 and 400 µM gallic acid treated cells respectively
depicting loss in genomic DNA. J. Clin. Biochem. Nutr. | January 2011 | vol. 48 | no. 1 | 89
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The radioprotective properties of GA have been determined by
an independent study in our laboratory.(19) Even administration of
GA alone has been shown to have anti-tumor effect and provides
evidence that GA can be used alone or as a combination therapy
with radiation. Being a dietary constituent it is readily available
in natural form and is not expensive in terms of purification of
the compound. Since GA is found in micro molar concentrations
in the human urine, it rules out any possible cytotoxicity to
neighboring healthy cells. Hence GA provides with an ideal
choice in the treatment of lung cancer.
In conclusion our studies proves that GA induces cell death in
A549 lung carcinoma cells in a dose dependent manner and
induced apoptosis by elevation ROS, disrupting MMP, and
activating caspase-3.
Fig. 5. Intracellular ROS level in A549 cells after gallic acid treatment. A–C: The A549 cell images treated with 0, 100 and 200 µM gallic acid for 2 h
and capture using fluorescence microscope at 40× objective. D: The level of ROS in A549 cells treated with 0, 100 and 200 µM gallic acid for 1 and 2 h
as measured by fluorimetry. ***: p<0.001.
*
Fig. 6. Loss in mitochondrial membrane potential: graph represents
the change in mitochondrial potential in A549 cells treated with
200 µM gallic acid for 1 h as measured by fluorimetry. *: p<0.05. Fig. 7. Changes in the level of Caspase 3 activity at 1, 3 and 6 h after
gallic acid treatments. *: p<0.05; **: p<0.05.doi: 10.3164/jcbn.11 004FR
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Abbreviations
GA 3,4 5-triphydroxyl-benzoic acid
MTT 3-[4,5-methylthiazol-2-yl]-2,5-diphenyl-tetrazolium
bromide
DMEM Dulbecco’s modified Eagle’s medium
FBS fetal bovine serum
PBS phosphate buffered saline
TBE Tris-borate-EDTA
ROS reactive oxygen species
DCFH-DA 2',7'-dichlorfluorescein-diacetate
Dio6 3,3'-dihexyloxacarboxyanine iodide
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